Status | Study |
Completed |
Study Name: Tipifarnib in Treating Older Patients With Acute Myeloid Leukemia Condition: Adult Acute Megakaryoblastic Leukemia Adult Acute Monoblastic Leukemia Date: 2011-05-24 Interventions: Drug: Tipifarnib Given PO |
Active, not recruiting |
Study Name: Lenalidomide in Patients With Chronic Myelomonocytic Leukemia Condition: Chronic Myelomonocytic Leukemia Date: 2011-05-09 Interventions: Drug: Revlimid Dose escalation 5mg - 10mg - 15mg - 20mg in |
Completed |
Study Name: A Study of 5-Azacitidine (Vidaza®) in Patients With Chronic Myelomonocytic Leukemia Condition: Chronic Myelomonocytic Leukemia Date: 2011-04-29 Interventions: Drug: 5-Azacitidine Administered on Days 1-7 of each Cycle |
Active, not recruiting |
Study Name: Caspofungin Acetate or Fluconazole in Preventing Invasive Fungal Infections in Patients With Acute Myeloid Leukemia Who Are Undergoing Chemotherapy Condition: Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Minimally Differentiated Myeloid Leuk Date: 2011-03-01 Interventions: Drug: caspofungin acetate Give |
Active, not recruiting |
Study Name: Multicenter Study to Assess the Efficacy of Decitabine in the Treatment of Chronic Myelomonocytic Leukemia Condition: Chronic Myelomonocytic Leukemia Date: 2010-12-01 Interventions: Drug: Decitabine Decitabine will be administered at a dose of 20 mg/m2 infused over a 1 hour period once |
Completed |
Study Name: Azacitidine in Treating Patients With Chronic Myelomonocytic Leukemia Condition: Leukemia Date: 2010-11-04 Interventions: Drug: azacitidine Other: laboratory biomar |
Completed |
Study Name: High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin Lymphoma Condition: Accelerated Phase Chronic Myelogenous Leukemia Adult Acute Lymphoblastic Leukemia in Remissi Date: 2010-08-05 Interventions: Drug: busulfan Given orally |
Completed |
Study Name: Pilot Study of Erlotinib for the Treatment of Patients With de Novo Acute Myeloid Leukemia Condition: Leukemia, Myelomonocytic, Acute Date: 2010-07-30 Interventions: Drug: Erlotinib Erlotinib will be administered orally at 150 mg once a day, continuously. Each cycle wil |
Completed |
Study Name: Decitabine in Patients With Chronic Myelomonocytic Leukemia (CMML) Condition: Chronic Myelomonocytic Leukemia Date: 2010-04-01 Interventions: Drug: Decitabine 20mg/m2/day, one hour intravenous infusion, every day during 5 days |
Recruiting |
Study Name: The Expression of PTEN Protein and mRNA in Malignant Cells of Chronic Myelomonocytic Leukemia Condition: Chronic Myelomonocytic Leukemia Date: 2009-11-06 |